We are live on ! Find out more
OM icon

Outset Medical

138 hedge funds and large institutions have $760M invested in Outset Medical in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 41

5% more capital invested

Capital invested by funds: $721M → $760M (+$38.2M)

0.13% less ownership

Funds ownership: 6.76%6.63% (-0.13%)

7% less funds holding

Funds holding: 149138 (-11)

36% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 28

87% less call options, than puts

Call options by funds: $229K | Put options by funds: $1.79M

Holders
138
Holders Change
-11
Holders Change %
-7.38%
% of All Funds
2.38%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
52
Reduced
41
Closed
28
Calls
$229K
Puts
$1.79M
Net Calls
-$1.56M
Net Calls Change
-$8.98M
Name Holding Trade Value Shares
Change
Change in
Stake
Squarepoint
76
Squarepoint
New York
$322K -$773K -2,885 -68%
Mirae Asset Global Investments
77
Mirae Asset Global Investments
South Korea
$322K -$354K -1,321 -50%
State Board of Administration of Florida Retirement System
78
State Board of Administration of Florida Retirement System
Florida
$322K
BCI
79
Brinker Capital Investments
Pennsylvania
$316K +$70.4K +263 +25%
Millennium Management
80
Millennium Management
New York
$301K -$1.1M -4,111 -77%
Manulife (Manufacturers Life Insurance)
81
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$301K -$12.6K -47 -4%
VOYA Investment Management
82
VOYA Investment Management
Georgia
$293K
Legal & General Group
83
Legal & General Group
United Kingdom
$285K -$80.9K -302 -20%
Man Group
84
Man Group
United Kingdom
$285K +$319K +1,193 New
MAM
85
Must Asset Management
South Korea
$259K
GCP
86
GSA Capital Partners
United Kingdom
$257K +$288K +1,074 New
CIBC Private Wealth Group
87
CIBC Private Wealth Group
Georgia
$257K +$288K +1,075 New
Susquehanna International Group
88
Susquehanna International Group
Pennsylvania
$233K +$261K +973 New
BCM
89
Bayesian Capital Management
New York
$233K +$261K +976 New
Federated Hermes
90
Federated Hermes
Pennsylvania
$223K +$250K +933 New
Envestnet Asset Management
91
Envestnet Asset Management
Illinois
$211K +$18.7K +70 +9%
Principal Financial Group
92
Principal Financial Group
Iowa
$198K -$5.36K -20 -2%
DT
93
Diversified Trust
Tennessee
$186K +$23.6K +88 +13%
PIM
94
Perpetual Investment Management
Australia
$184K +$9.64K +36 +5%
ASRS
95
Arizona State Retirement System
Arizona
$176K +$2.14K +8 +1%
Cerity Partners
96
Cerity Partners
New York
$174K +$195K +730 New
Public Employees Retirement Association of Colorado
97
Public Employees Retirement Association of Colorado
Colorado
$130K
SG Americas Securities
98
SG Americas Securities
New York
$128K -$175K -653 -55%
IA
99
IFP Advisors
Florida
$122K +$268 +1 +0.8%
AB
100
Amalgamated Bank
New York
$122K +$2.14K +8 +2%

OM Hedge Fund Activity: Q3 2022 in Review

138 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2022, worth a combined $760M — up 5.3% from $721M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of OM and 18 opened new positions — a net loss of 10 holders — while 41 trimmed existing stakes and 52 added.

The largest buyer was PFM Health Sciences, opening a new position worth an estimated $13M. The largest seller was T. Rowe Price Associates, cutting an estimated $50.2M.

  • 138 institutional investors held Outset Medical (OM) as of Q3 2022, down from 149 in Q2 2022.
  • Funds reported $760M of Outset Medical stock for Q3 2022, up 5.3% quarter-over-quarter.
  • 18 funds opened new Outset Medical positions in Q3 2022 and 28 closed out, a net change of -10 holders.
  • The largest Outset Medical buyer in Q3 2022 was PFM Health Sciences, an estimated $13M added.
  • The largest Outset Medical seller in Q3 2022 was T. Rowe Price Associates, an estimated $50.2M sold.

Based on aggregated 13F filings for Q3 2022.